Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives

被引:0
|
作者
Ren, Dekang [1 ,2 ]
Xiong, Shizheng [1 ,2 ]
Ren, Yujie [1 ,2 ]
Yang, Xueni [1 ,2 ]
Zhao, Xinmiao [1 ,2 ]
Jin, Jiaming [1 ,2 ]
Xu, Miaomiao [1 ,2 ]
Liang, Tingming [3 ]
Guo, Li [1 ,2 ]
Weng, Lixing [1 ,2 ]
机构
[1] Nanjing Univ Posts & Telecommun, State Key Lab Organ Elect & Informat Displays, Nanjing 210023, Peoples R China
[2] Nanjing Univ Posts & Telecommun, Inst Adv Mat IAM, Nanjing 210023, Peoples R China
[3] Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Peoples R China
关键词
Adjuvants; Therapeutic cancer vaccines; In situ vaccination; Immunogenic cell death; IMMUNOGENIC CELL-DEATH; SENSITIZE TUMORS; FAMILY CYTOKINES; PROSTATE-CANCER; SIPULEUCEL-T; IMMUNOTHERAPY; DELIVERY; CD8(+); NANOMEDICINE; PREVENTION;
D O I
10.1016/j.csbj.2024.04.054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Preventive cancer vaccines are highly effective in preventing viral infection-induced cancer, but advances in therapeutic cancer vaccines with a focus on eliminating cancer cells through immunotherapy are limited. To develop therapeutic cancer vaccines, the integration of optimal adjuvants is a potential strategy to enhance or complement existing therapeutic approaches. However, conventional adjuvants do not satisfy the criteria of clinical trials for therapeutic cancer vaccines. To improve the effects of adjuvants in therapeutic cancer vaccines, effective vaccination strategies must be formulated and novel adjuvants must be identified. This review offers an overview of the current advancements in therapeutic cancer vaccines and highlights in situ vaccination approaches that can be synergistically combined with other immunotherapies by harnessing the adjuvant effects. Additionally, the refinement of adjuvant systems using cutting-edge technologies and the elucidation of molecular mechanisms underlying immunogenic cell death to facilitate the development of innovative adjuvants have been discussed.
引用
收藏
页码:1833 / 1843
页数:11
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
    Borella, Fulvio
    Ghisoni, Eleonora
    Giannone, Gaia
    Cosma, Stefano
    Benedetto, Chiara
    Valabrega, Giorgio
    Katsaros, Dionyssios
    [J]. DIAGNOSTICS, 2020, 10 (03)
  • [32] Harnessing DNA as a Designable Scaffold for Asymmetric Catalysis: Recent Advances and Future Perspectives
    Yum, Ji Hye
    Sugiyama, Hiroshi
    Park, Soyoung
    [J]. CHEMICAL RECORD, 2022, 22 (06):
  • [33] Cancer vaccines: Advances give hope for future therapy
    Thompson, T
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14) : 1044 - 1046
  • [34] Cancer mRNA vaccines: clinical advances and future opportunities
    Sayour, Elias J.
    Boczkowski, David
    Mitchell, Duane A.
    Nair, Smita K.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (07) : 489 - 500
  • [35] Expanding the Potential of Neoantigen Vaccines: Harnessing Bacille Calmette-Guerin Cell-Wall-Based Nanoscale Adjuvants for Enhanced Cancer Immunotherapy
    Liu, Kangkang
    Peng, Jing
    Guo, Yunfei
    Li, Yiming
    Qi, Xiang
    Duan, Dengyi
    Li, Taipeng
    Li, Jianmin
    Niu, Yuanjie
    Han, Gang
    Zhao, Yang
    [J]. ACS NANO, 2024, 18 (18) : 11910 - 11920
  • [36] Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives
    Kocher, Jacob
    Yuan, Lijuan
    [J]. FUTURE VIROLOGY, 2015, 10 (07) : 899 - 913
  • [37] Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
    Mocellin, S.
    Pilati, P.
    Nitti, D.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2009, 16 (36) : 4779 - 4796
  • [38] Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
    Cao, Lei-Ming
    Yu, Yi-Fu
    Li, Zi-Zhan
    Zhong, Nian-Nian
    Wang, Guang-Rui
    Xiao, Yao
    Liu, Bing
    Wu, Qiu-Ji
    Feng, Chun
    Bu, Lin-Lin
    [J]. JOURNAL OF NANOBIOTECHNOLOGY, 2024, 22 (01)
  • [39] Therapeutic HIV vaccines: Prior setbacks, current advances, and future prospects
    Fisher, Kevin
    Voronin, Yegor
    Jefferys, Richard
    [J]. VACCINE, 2014, 32 (43) : 5540 - 5545
  • [40] Advances in Cervical Cancer Control and Future Perspectives
    Grce, Magdalena
    Matovina, Mihaela
    Milutin-Gasperov, Nina
    Sabol, Ivan
    [J]. COLLEGIUM ANTROPOLOGICUM, 2010, 34 (02) : 731 - 736